Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial-Reference-Cited by-同舟云学术

Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Published:2012-03-19 Issue:7 Volume:110 Page:1050-1059
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Sutcliffe Siobhan,Grubb III Robert L.,Platz Elizabeth A.,Ragard Lawrence R.,Riley Thomas L.,Kazin Sally S.,Hayes Richard B.,Hsing Ann W.,Andriole Gerald L.,

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2011.10867.x/fullpdf

Reference23 articles.

1. Inflammation and benign prostatic hyperplasia;Nickel;Urol Clin North Am,2008

2. Role of chronic inflammation in the promotion of prostatic hyperplasia in rats;Kessler;J Urol,1998

3. Sex-hormone-induced inflammation and fibromuscular proliferation in the rat lateral prostate;Robinette;Prostate,1988

4. Chronic prostatitis in benign prostatic hyperplasia;Odunjo;Br J Urol,1971

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benign prostatic hyperplasia nodules in patients treated with celecoxib and/or finasteride have reduced levels of NADH dehydrogenase [ubiquinone] iron‐sulfur protein 3, a mitochondrial protein essential for efficient function of the electron transport chain;The Prostate;2024-07-14

2. Body size throughout the life-course and incident benign prostatic hyperplasia-related outcomes and nocturia;BMC Urology;2021-03-27

3. Introduction to benign prostatic hyperplasia;Molecular Mechanisms of Nutritional Interventions and Supplements for the Management of Sexual Dysfunction and Benign Prostatic Hyperplasia;2021

4. Diet as a risk factor and intervention for lower urinary tract symptoms secondary to benign prostatic hyperplasia;Molecular Mechanisms of Nutritional Interventions and Supplements for the Management of Sexual Dysfunction and Benign Prostatic Hyperplasia;2021

5. Review of the Roles and Interaction of Androgen and Inflammation in Benign Prostatic Hyperplasia;Mediators of Inflammation;2020-10-28